republic-os/legislation/us/states/ca/20172018/ab-1386.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Genomic cancer testing information.	Existing law requires a physician and surgeon, as defined, to give a patient diagnosed with breast cancer a standardized written summary, made available to physicians and surgeons by the Medical Board of California, containing recommendations of the Cancer Advisory Council, to inform the patient of the advantages, disadvantages, risks, and descriptions of the procedures with regard to medically viable and efficacious alternative methods of breast cancer treatment. The summary is required to be revised every 3 years and include any new or revised information, as specified.	us/states/ca	California Legislature	20172018	AB 1386	California AB 1386 (20172018)	bill	Genomic cancer testing information.	enacted	Waldron	9	28	8	2017-02-17	2017-10-12	openstates	ocd-bill/2817cee8-c198-4adb-81dd-d2c01ff6f853	http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201720180AB1386	4b6f98333daa959c6a20fbfa10d905c719690276188b373ec399d3f5bcb1024e	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-ca

California AB 1386 (20172018) — Genomic cancer testing information.

Existing law requires a physician and surgeon, as defined, to give a patient diagnosed with breast cancer a standardized written summary, made available to physicians and surgeons by the Medical Board of California, containing recommendations of the Cancer Advisory Council, to inform the patient of the advantages, disadvantages, risks, and descriptions of the procedures with regard to medically viable and efficacious alternative methods of breast cancer treatment. The summary is required to be revised every 3 years and include any new or revised information, as specified.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. 02/17/17 - Introduced (filed) — source
2. 03/30/17 - Amended Assembly (committee substitute) — source
3. 04/19/17 - Amended Assembly (committee substitute) — source
4. 05/26/17 - Amended Assembly (committee substitute) — source
5. 07/17/17 - Amended Senate (committee substitute) — source
6. 09/01/17 - Amended Senate (committee substitute) — source
7. 10/12/17 - Chaptered (committee substitute) — source
8. AB1386 (committee substitute) — source
9. 09/13/17 - Enrolled (enrolled) — source

Votes

• Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar — 14–0 (pass) · lower
• AB 1386 WALDRON Concurrence in Senate Amendments — 78–0 (pass) · lower
• Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] with the recommendation: To Consent Calendar — 8–0 (pass) · upper
• Do pass as amended. — 16–0 (pass) · lower
• AB 1386 WALDRON Assembly Third Reading — 76–0 (pass) · lower
• Do pass as amended — 7–0 (pass) · upper
• 3rd Reading AB1386 Waldron et al. By Leyva — 40–0 (pass) · upper
• Placed on suspense file — 7–0 (pass) · upper

Sponsors

• Waldron — primary (person)
• Atkins — principal coauthor (person)
• Caballero — principal coauthor (person)
• Cristina Garcia — principal coauthor (person)
• Leyva — principal coauthor (person)
• Skinner — principal coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2017-02-17 Read first time. To print. reading-1
• 2017-02-19 From printer. May be heard in committee March 21.
• 2017-03-30 Referred to Com. on HEALTH. referral-committee
• 2017-03-30 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. amendment-introduction, amendment-passage, reading-2, reading-1
• 2017-04-03 Re-referred to Com. on HEALTH. referral-committee
• 2017-04-19 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. amendment-introduction, amendment-passage, reading-2, reading-1
• 2017-04-20 Re-referred to Com. on HEALTH. referral-committee
• 2017-04-26 From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 25). Re-referred to Com. on APPR. committee-passage-favorable, committee-passage, referral-committee
• 2017-05-10 In committee: Set, first hearing. Referred to APPR. suspense file. referral-committee
• 2017-05-26 From committee: Amend, and do pass as amended. (Ayes 16. Noes 0.) (May 26). amendment-passage, committee-passage, amendment-introduction
• 2017-05-26 Read second time and amended. Ordered returned to second reading. reading-1, amendment-passage, reading-2
• 2017-05-30 Read second time. Ordered to third reading. reading-2, reading-1
• 2017-05-31 Measure version as amended on May 26 corrected. amendment-passage
• 2017-05-31 Read third time. Passed. Ordered to the Senate. (Ayes 76. Noes 0. Page 1945.) reading-3, passage, reading-1
• 2017-06-01 In Senate. Read first time. To Com. on RLS. for assignment. reading-1
• 2017-06-14 Referred to Com. on HEALTH. referral-committee
• 2017-07-13 From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 8. Noes 0.) (July 12). amendment-passage, committee-passage, amendment-introduction
• 2017-07-17 Read second time and amended. Re-referred to Com. on APPR. amendment-passage, reading-2, referral-committee, reading-1
• 2017-08-21 In committee: Referred to APPR. suspense file. referral-committee
• 2017-09-01 From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (September 1). amendment-passage, committee-passage, amendment-introduction
• 2017-09-01 Read second time and amended. Ordered returned to second reading. reading-1, amendment-passage, reading-2
• 2017-09-05 Read second time. Ordered to third reading. reading-2, reading-1
• 2017-09-07 Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 2577.). reading-3, passage, reading-1
• 2017-09-07 In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 9 pursuant to Assembly Rule 77.
• 2017-09-11 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 3145.). committee-passage-favorable, amendment-passage
• 2017-09-19 Enrolled and presented to the Governor at 3 p.m.
• 2017-10-12 Approved by the Governor. executive-signature
• 2017-10-12 Chaptered by Secretary of State - Chapter 693, Statutes of 2017.

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/2817cee8-c198-4adb-81dd-d2c01ff6f853. Confidence: reported (aggregated from official California legislature records).